The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.

U.S. cancer centers are scrambling to enroll patients in an early access program for a highly promising pancreatic cancer ​drug from Revolution Medicines while they await what they hope will be a ...

If you click on links we provide, we may receive compensation. "Every moment of the 'Schmigadoon!' process, I have to remind my body and my brain that we're not back there," the actress says ANGELA ...

Zoci Intracranial ORR -- Achieved a 62.5% confirmed intracranial overall response rate and nearly 69% best overall ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Kylie Minogue exclusively tells HELLO! about her new three-part Netflix documentary, which tells her fascinating life story, including her close bonds with Jason Donovan and the late Michael Hutchence ...

A new drug for pancreatic cancer gives some hope for one of the most dire types of cancer.

Revolution Medicines offers early access to daraxonrasib, a pancreatic cancer drug doubling survival, as U.S. cancer centers manage patient enrollment.

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for ...

A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer ...

First-in-human pancreatic cancer trial at WVU tests an implant that delivers chemotherapy directly into tumors using low-voltage electric pulses. The WVU Cancer Institute is helping lead a global ...

Chemotherapy can save lives, but anyone who has watched a loved one go through it knows how hard it can be. The nausea. The exhaustion. The infections. The days when even getting off the couch feels ...